Scott Akamine - Chief Legal Officer at Cerevel Therapeutics Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Legal Officer
Stock Symbol
CERE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Scott Akamine - trading volume in the past year for Cerevel Therapeutics Holdings, Inc.

Holdings reported by Scott Akamine for Cerevel Therapeutics Holdings, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 59,171 $2.5 M $42.24 Jan 19, 2024 Direct Common Stock
Common Stock 7,237 $306 K $42.24 Dec 20, 2023 Direct
Stock Option (Right to Buy) 254,262 Dec 7, 2023 Direct Common Stock

Transactions reported by Scott Akamine for Cerevel Therapeutics Holdings, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership